a fully human monoclonal antibody Linguee +人工智能=DeepL翻译器 翻译较长的文本,请使用世界上最好的在线翻译! ▾ 英语-中文正在建设中 fully— 充分 · 完全形 · 满 · 充分地副 · 足足 · 全力副 · 全面地副 · 整整副 · 完全地副
待解决 悬赏分:1 - 离问题结束还有 a fully human monoclonal antibody问题补充:匿名 2013-05-23 12:21:38 一个完全的人类单克隆抗体 匿名 2013-05-23 12:23:18 一个充分地人的单克抗体 匿名 2013-05-23 12:24:58 正在翻译,请等待... 匿名 2013-05-23 12:26:38 完全人的单克隆抗体 匿名 201...
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signal- ing and inhibits human tumor growth in vivo. Cancer Res 2003;63: 8912- 8921.Burtrum D, Zhu Z, Lu D, et al. A fully human monoclonal anti- body to the insulin-like growth ...
YUMAB, a global provider of fully human monoclonal antibodies, offers ultra-fast discovery and efficient lead development. The company is looking to expand its network of collaborators and clients through flexible licensing options for diagnostics and th
A fully monoclonal antibody (CS-D7, IgG1) specific for the iron regulated surface determinant B (IsdB) of was isolated from the Cambridge Antibody Technology () scFv antibody library. As compared to previously described IsdB specific monoclonals, CS-D7 has a unique, non-overlapping site on ...
Purpose: P-cadherin is a membrane glycoprotein that functionally mediates tumor cell adhesion, proliferation, and invasiveness. We characterized the biological properties of PF-03732010, a human monoclonal antibody against P-cadherin, in cell-based assays and tumor models.Experimental Design: The affinity...
This article provides a review of human monoclonal antibody tanibirumab (TTAC-0001), which specifically binds VEGFR-2 and is currently being developed in preclinical stage by PharmAbcine (Daejon, Korea). 展开 关键词: Analgesic and Anti-inflammatory Activities Dibenzobarallene Isoindoles Secondary ...
AlliancesAsiaEurope MORE ON THIS TOPIC Layoffs Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization November 7, 2024 · 2 min read · Angela Gabriel Earnings Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints...
Panitumumab is the first fully human monoclonal antibody that binds to EGFr. Clinical activity has been demonstrated, most notably in patients with EGFr-positive metastatic colorectal cancer who have failed prior therapy. Phase III study results indicate a 46% reduction in the rate of tumor ...
Accordingly, the present disclosure provides monoclonal antibodies comprising one or more heavy and/or light chain CDR3 domains from an antibody derived from a human or non-human animal, wherein the monoclonal antibody is capable of specifically binding to VAP-1. Within certain aspects, the ...